Genedia Biotech Co., Ltd.
Records under this name other than patents Genedia Biotech Co., Ltd. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 5 of 5 · Back to Genedia Biotech Co., Ltd.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,127,320 | MIR-193A-3P and Associated Genes Predict Tumorigenesis and Chemotherapy Outcomes Lapsed on the fee record Ended Sep 8, 2023 · High confidence | Lapsed on the fee record | Ended Sep 8, 2023 | High confidence |
| US 10,238,688 | Combination Therapies for Bladder Cancer Lapsed on the fee record Ended Mar 26, 2023 · High confidence | Lapsed on the fee record | Ended Mar 26, 2023 | High confidence |
| US 10,161,008 | MIR-193A-3P and Associated Genes Predict Tumorigenesis and Chemotherapy Outcomes Lapsed on the fee record Ended Dec 25, 2022 · High confidence | Lapsed on the fee record | Ended Dec 25, 2022 | High confidence |
| US 10,011,877 | Treatment of Bladder Cancer to Overcome Chemoresistance Lapsed on the fee record Ended Jul 3, 2022 · High confidence | Lapsed on the fee record | Ended Jul 3, 2022 | High confidence |
| US 9,540,698 | MIR-193A-3P and Associated Genes Predict Tumorigenesis and Chemotherapy Outcomes Lapsed on the fee record Ended Jan 10, 2021 · High confidence | Lapsed on the fee record | Ended Jan 10, 2021 | High confidence |